Skip to content

Client Update: Where there’s smoke, there may be coverage: an insurer’s obligation to indemnify for medical cannabis

Jon O’Kane and Jamie Watson

Legal cannabis will have numerous implications for insurers. The federal Cannabis Act (discussed here), the provincial acts (discussed here) and the regulations (discussed here) are all going to add layers of nuance to the governance of cannabis in Canada.

Auto insurers will be affected by the uncertainty created by impaired driving, as we discuss in our article: Driving high – the future is hazy for Canadian automobile insurers once cannabis goes legal. However, other insurers, who deal with health and benefits, are already grappling with medical cannabis and coverage – as is discussed in the Nova Scotia Human Rights Tribunal decision of Skinner v Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund, 2017 CanLII 3240 (NS HRC) (“Skinner“).

Skinner: what is it about?

Gordon “Wayne” Skinner worked for ThyssenKrupp Elevator Canada when he was injured on the job in a motor vehicle accident in 2010. After two other medications became ineffective in managing his symptoms, Mr. Skinner obtained a medical cannabis license in 2012. Once he exhausted his employer’s insurer’s coverage limit of $25,000, Mr. Skinner turned to the Canadian Elevator Industry Welfare Trust Plan (the “Trust”) to cover his medicinal cannabis. The Trust provides health and related benefits for employees and former employees working in the unionized sector of the Canadian elevator industry.

The Trust denied the request for coverage, taking the position that (a) medical cannabis had not been approved by Health Canada and, consequently, lacked a drug identification number (“DIN”); and, (b) Skinner’s injuries were the result of an otherwise compensable workplace accident and therefore ought to be covered by the provincial Medicare plan.

Mr. Skinner complained to the Nova Scotia Human Rights Commission (the “Commission”). Earlier this year, a Board of Inquiry (“BOI”) issued its decision. The BOI concluded that denial of coverage for medical cannabis amounted to unjustifiable discrimination and ordered the Trust to reimburse certain expenses.

Skinner provides guidance on how to draft language limiting coverage for medical cannabis within an insurance or group benefits policy. However, the impact of this decision may change, as an appeal is presently slated for October 2017 before the Nova Scotia Court of Appeal.

Skinner’s implications for insurers and coverage providers (at present)

1. Medical cannabis should be explicitly excluded from coverage, if that is the intent.

In Skinner, the BOI concluded it was not necessary that cannabis be assigned a DIN as a condition for coverage. Since the Trust’s plan in Skinner included coverage for both “drugs” and “medicines”, the BOI concluded it was prima facie discriminatory to deny coverage for medical cannabis as opposed to other medicines (thereby imposing a burden on the Trust to prove that the denial was justifiable).

2. Coverage for medical cannabis cannot be denied arbitrarily. Insurers or benefit providers seeking to deny coverage must be able to justify that decision with evidence.

In Skinner, there was little evidence presented that showed coverage of medicinal cannabis would have rendered the Trust financially unviable. The Trust argued it would cost $60 per day to provide the medicinal cannabis to Mr. Skinner when justifying the alleged discrimination and denial of coverage. The BOI concluded that absent any context or comparators, the $60 daily expense to the Trust was not prohibitive to providing coverage to Mr. Skinner. Furthermore, the BOI decided that exclusion of medical cannabis was contrary to the purpose of the Trust’s plan, which was to maximize the benefits for members without compromising the financial viability of the trust funds supporting the plan.

Skinner‘s future implications 

Two items will have direct impacts on Skinner‘s continuing utility as a precedent in this area:

1. Legalized recreational cannabis, which is fast approaching, will require insurers and benefit providers to think critically about the relationship and overlap between recreational and medicinal cannabis when drafting coverage provisions; and,

2. The results of the October, 2017 appeal before the Nova Scotia Court of Appeal, which we will be following closely.

SHARE

Archive

Search Archive


 
 

In-depth: economic response measures to COVID-19

April 6, 2020

*Last updated: April 9, 2020 Maurice Chiasson, QC , Sara Scott, P. Eng, Madeleine Coats and Justin Song (송진원) The provincial and federal governments are working in tandem to provide support to businesses during the…

Read More

Estate planning during a pandemic: innovative practices for a challenging time

April 3, 2020

Richard Niedermayer, TEP The current COVID-19 pandemic and the resulting declarations of states of emergency, public health orders and national guidelines on travel, business openings, self-isolation and social distancing have affected everyone in Canada and…

Read More

Newfoundland and Labrador passes law to allow variation of limitation periods and statutory timelines during COVID-19 pandemic

April 2, 2020

Joe Thorne On March 26, 2020, the COVID-19 Pandemic Response Act received Royal Assent. Among other things, that statute brought into force the Temporary Variation of Statutory Deadlines Act (the “Act”).1 The Act addresses concerns…

Read More

Nova Scotia’s new Tourist Accommodations Registration Act

April 1, 2020

Brian Tabor, QC and Jennifer Murphy On April 1, 2020, Nova Scotia’s new Tourist Accommodations Registration Act and its regulations come into force, repealing and replacing the Tourist Accommodations Act. With the exception of those…

Read More

Tax Planning: Warming up to the refreeze in a COVID-19-impacted economy

March 30, 2020

Stephanie Stapleford and Brent McCumber, P.Eng. In the span of mere months, COVID-19 has significantly impacted lives and livelihoods all over the world. The pandemic has affected individuals’ health, well-being and financial stability, and measures…

Read More

Nova Scotia Commercial Rent Deferral Support Program: COVID-19 Economic Response

March 29, 2020

*Last updated: March 31, 2020 Brian Tabor, QC, Matthew Newell, Colin Piercey and Madeleine Coats On March 27, 2020, Premier Stephen McNeil announced further business supports in response to the ongoing COVID-19 pandemic. This includes…

Read More

Government of Newfoundland and Labrador creates protected leave of absence amidst COVID-19

March 27, 2020

Twila Reid and Sarah Byrne On March 26, 2020, the Newfoundland House of Assembly met with a minimum quorum of members to table and pass Bill 33 – COVID-19 Pandemic Response Act (“Act”). This omnibus…

Read More

Tax update – response to COVID-19

March 26, 2020

Brent McCumber, P.Eng. On March 24, 2020, the Government of Canada introduced legislation to implement its economic response plan to COVID-19, namely, the COVID-19 Emergency Response Act ( “Emergency Response Act”).  This legislation received Royal…

Read More

Business interruption insurance: are your business losses covered during the COVID-19 crisis?

March 25, 2020

Colin Piercey and Sam Ward During this unprecedented crisis, almost all businesses have been negatively affected. Some have been forced to shut down entirely while others have been severely curtailed in their ability to earn…

Read More

COVID-19 and contractual review

March 24, 2020

Daniela Bassan, QC and Scott Pike The World Health Organization declared the COVID-19 outbreak as a pandemic on March 11, 2020. Bracing for the strain on health-care systems, authorities have enacted drastic measures designed to…

Read More

Search Archive


Scroll To Top